Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Innate Pharma SA

+ Add to Watchlist

IPH:FP

15.8500 EUR 0.3500 2.26%

As of 05:39:22 ET on 05/06/2015.

Snapshot for Innate Pharma SA (IPH)

Open: 15.7400 Day's Range: 15.5600 - 15.9500 Volume: 319,630
Previous Close: 15.5000 52wk Range: 5.8500 - 17.8500 1-Yr Rtn: +146.88%

Stock Chart for IPH

No chart data available.
  • IPH:FP 15.8500
  • 1D
  • 1M
  • 1Y
15.5000
Interactive IPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IPH

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 83.1579
Relative P/E vs. CAC -
Earnings Per Share (EUR) (ttm) -0.3900
Est. EPS (EUR) (12/2015) 0.1900
Est. PEG Ratio -
Market Cap (M EUR) 840.15
Shares Outstanding (M) 53.17
30 Day Average Volume 1,486,331
Price/Book (mrq) 8.5358
Price/Sale (ttm) 814.9508
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IPH

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for IPH

Innate Pharma S.A. is a biopharmaceutical company. The Company develops first in class drugs that focus on cancer immunotherapy through the manipulation of the innate immune system.

Herve BraillyChairman-Mgmt Board/CEOPierre F DodionChief Medical Officer
Catherine MoukheibirExec VP/Senior Advisor:FinanceJerome TiollierExec VP/Chief Dev Officer
More Company Profile & Key Executives for IPH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil